Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-27

Clinical Trial Update: Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy [NA]

View source ↗

Summary

Completed results of a clinical trial evaluating eplerenone for subclinical cardiomyopathy in Duchenne muscular dystrophy, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

Sponsor: Subha Raman | Conditions: Duchenne Muscular Dystrophy | NA | Status: COMPLETED | Results posted: 2015-05-27